Skip to main content
Clinical Trials/JPRN-UMIN000001350
JPRN-UMIN000001350
Completed
未知

Early intervention for mild or borderline pulmonary arterial hypertension (PAH) associated with connective tissue diseases - Keio university clinical trial for early pulmonary arterial hypertension with connective tissue diseases (KEEP-ACTIVE study)

Keio University0 sites70 target enrollmentOctober 1, 2008

Overview

Phase
未知
Intervention
Not specified
Conditions
Pulmonary arterial hypertension (PAH) associated with connective tissue disease
Sponsor
Keio University
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 1, 2008
End Date
March 31, 2018
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Hypersensitivity to Sildenafil or Beraprost. 2\) Patients with chronic pulmonary thromboembolism. 3\) Patients who will be on home oxygen therapy 4\) Patients who will be classified as WHO class III or IV 5\) Patients with severe ischemic heart diseases or cardiomyopathy 6\) Patients with malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials